{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:23:06Z","timestamp":1794590586923,"version":"4.9.1"},"reference-count":33,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["consortium SFB\/TRR57 \u201cLiver fibrosis\u201d"],"award-info":[{"award-number":["consortium SFB\/TRR57 \u201cLiver fibrosis\u201d"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["grant STR1095\/6-1"],"award-info":[{"award-number":["grant STR1095\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014931","name":"Arrowhead Pharmaceuticals","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100014931","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EASL registry grant on alpha-1 antitrypsin-related liver disease","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2021,1,25]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Alpha-1 antitrypsin deficiency (AATD) is a common, potentially lethal inborn disorder caused by mutations in alpha-1 antitrypsin (AAT). Homozygosity for the \u2018Pi*Z\u2019 variant of AAT (Pi*ZZ genotype) causes lung and liver disease, whereas heterozygous \u2018Pi*Z\u2019 carriage (Pi*MZ genotype) predisposes to gallstones and liver fibrosis. The clinical significance of the more common \u2018Pi*S\u2019 variant remains largely undefined and no robust data exist on the prevalence of liver tumours in AATD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Baseline phenotypes of AATD individuals and non-carriers were analysed in 482\u2009380 participants in the UK Biobank. 1104 participants of a multinational cohort (586 Pi*ZZ, 239 Pi*SZ, 279 non-carriers) underwent a comprehensive clinical assessment. Associations were adjusted for age, sex, body mass index, diabetes and alcohol consumption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among UK Biobank participants, Pi*ZZ individuals displayed the highest liver enzyme values, the highest occurrence of liver fibrosis\/cirrhosis (adjusted OR (aOR)=21.7 (8.8\u201353.7)) and primary liver cancer (aOR=44.5 (10.8\u2013183.6)). Subjects with Pi*MZ genotype had slightly elevated liver enzymes and moderately increased odds for liver fibrosis\/cirrhosis (aOR=1.7 (1.2\u20132.2)) and cholelithiasis (aOR=1.3 (1.2\u20131.4)). Individuals with homozygous Pi*S mutation (Pi*SS genotype) harboured minimally elevated alanine aminotransferase values, but no other hepatobiliary abnormalities. Pi*SZ participants displayed higher liver enzymes, more frequent liver fibrosis\/cirrhosis (aOR=3.1 (1.1\u20138.2)) and primary liver cancer (aOR=6.6 (1.6\u201326.9)). The higher fibrosis burden was confirmed in a multinational cohort. Male sex, age \u226550\u2009years, obesity and the presence of diabetes were associated with significant liver fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study defines the hepatobiliary phenotype of individuals with the most relevant AATD genotypes including their predisposition to liver tumours, thereby allowing evidence-based advice and individualised hepatological surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2020-323729","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T13:20:10Z","timestamp":1614259210000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":73,"title":["Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency"],"prefix":"10.1136","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0382-5705","authenticated-orcid":false,"given":"Malin","family":"Fromme","sequence":"first","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin V","family":"Schneider","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Centro Hospitalar do Funchal, Madeira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-2746","authenticated-orcid":false,"given":"Karim","family":"Hamesch","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Pons","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Universitari Vall d\u2019Hebron, Vall d\u2019Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8192-0575","authenticated-orcid":false,"given":"Matthias C","family":"Reichert","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Benini","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Medicine, Spedali Civili and University, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ellis","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"H Thorhauge","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-0017","authenticated-orcid":false,"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Burbaum","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Woditsch","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chorostowska-Wynimko","sequence":"additional","affiliation":[{"name":"Department of Genetics and Clinical Immunology, National Tuberculosis and Lung Diseases Institute, Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Verbeek","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, KU Leuven University Hospitals Leuven, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, KU Leuven University Hospitals Leuven, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Leuven, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Genesca","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Universitari Vall d\u2019Hebron, Vall d\u2019Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[{"name":"Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d\u2019Hebron Institut de Recerca (VHIR), Vall d\u2019Hebron Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d\u2019Hebron Institut de Recerca (VHIR), Vall d\u2019Hebron Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Tirol, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Tirol, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Janciauskiene","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9lia","family":"Abreu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Centro Hospitalar do Funchal, Madeira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Jasmins","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Centro Hospitalar do Funchal, Madeira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-3844","authenticated-orcid":false,"given":"Rui","family":"Gaspar","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Faculty of Medicine of Porto University, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Liberal","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Faculty of Medicine of Porto University, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Macedo","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Faculty of Medicine of Porto University, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Mahadeva","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Cambridge University Hospitals, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Gomes","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar de Vila Nova de Gaia Espinho EPE, Vila Nova de Gaia, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Markus","family":"Schneider","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-6425","authenticated-orcid":false,"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-4932","authenticated-orcid":false,"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5223-1121","authenticated-orcid":false,"given":"Bibek","family":"Gooptu","sequence":"additional","affiliation":[{"name":"NIHR Leicester BRC-Respiratory and Leicester Institute of Structural & Chemical Biology, University of Leicester, Leicester, Leicestershire, UK"},{"name":"London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[{"name":"London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK"},{"name":"Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Marshall","sequence":"additional","affiliation":[{"name":"London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK"},{"name":"Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7246-6040","authenticated-orcid":false,"given":"John R","family":"Hurst","sequence":"additional","affiliation":[{"name":"London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK"},{"name":"UCL Respiratory, Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2339-6979","authenticated-orcid":false,"given":"David A","family":"Lomas","sequence":"additional","affiliation":[{"name":"London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK"},{"name":"UCL Respiratory, Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany"},{"name":"Hannover Medical School (MHH), Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine T","family":"Gaisa","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Clark","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice M","family":"Turner","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel G","family":"McElvaney","sequence":"additional","affiliation":[{"name":"Irish Centre for Genetic Lung Disease, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7122-6379","authenticated-orcid":false,"given":"Pavel","family":"Strnad","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"2025112102450609000_71.2.415.1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-Antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"key":"2025112102450609000_71.2.415.2","doi-asserted-by":"crossref","first-page":"16051","DOI":"10.1038\/nrdp.2016.51","article-title":"\u03b11-Antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025112102450609000_71.2.415.3","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1056\/NEJMcp0900449","article-title":"Clinical practice. alpha1-antitrypsin deficiency","volume":"360","author":"Silverman","year":"2009","journal-title":"N Engl J Med"},{"key":"2025112102450609000_71.2.415.4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jhep.2018.08.005","article-title":"Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort","volume":"69","author":"Clark","year":"2018","journal-title":"J Hepatol"},{"key":"2025112102450609000_71.2.415.5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cld.2018.06.010","article-title":"Alpha-1-Antitrypsin deficiency liver disease","volume":"22","author":"Patel","year":"2018","journal-title":"Clin Liver Dis"},{"key":"2025112102450609000_71.2.415.6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2019.05.013","article-title":"Liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the Pi*ZZ mutation","volume":"157","author":"Hamesch","year":"2019","journal-title":"Gastroenterology"},{"key":"2025112102450609000_71.2.415.7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.gastro.2020.04.058","article-title":"Liver phenotypes of European adults heterozygous or homozygous for Pi\u2217Z variant of AAT (Pi\u2217MZ vs Pi\u2217ZZ genotype) and noncarriers","volume":"159","author":"Schneider","year":"2020","journal-title":"Gastroenterology"},{"key":"2025112102450609000_71.2.415.8","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/COPD.S137852","article-title":"Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of sz subjects worldwide","volume":"12","author":"Blanco","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025112102450609000_71.2.415.9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1753465812457113","article-title":"Prevalence of \u03b11-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review","volume":"6","author":"de Serres","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"2025112102450609000_71.2.415.10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/15412555.2015.1021912","article-title":"Spanish registry of patients with alpha-1 antitrypsin deficiency; comparison of the characteristics of PISZ and PIZZ individuals","volume":"12 Suppl 1","author":"Lara","year":"2015","journal-title":"COPD"},{"key":"2025112102450609000_71.2.415.11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/rccm.202002-0262OC","article-title":"Clarifying the risk of lung disease in sz alpha-1 antitrypsin deficiency","volume":"202","author":"Franciosi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025112102450609000_71.2.415.12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/liv.14035","article-title":"Liver disease related to alpha1-antitrypsin deficiency in French children: the DEFI-ALPHA cohort","volume":"39","author":"Ruiz","year":"2019","journal-title":"Liver Int"},{"key":"2025112102450609000_71.2.415.13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MPG.0000000000000753","article-title":"Baseline analysis of a young \u03b1-1-antitrypsin deficiency liver disease cohort reveals frequent portal hypertension","volume":"61","author":"Teckman","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025112102450609000_71.2.415.14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.14537","article-title":"Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease","volume":"47","author":"Townsend","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112102450609000_71.2.415.15","unstructured":"Strnad P , Brantly ML , Bals R . Alpha-1-Antitrypsin deficiency (ERS monograph) 2019."},{"key":"2025112102450609000_71.2.415.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/570679","article-title":"Is PiSS alpha-1 antitrypsin deficiency associated with disease?","volume":"2010","author":"McGee","year":"2010","journal-title":"Pulm Med"},{"key":"2025112102450609000_71.2.415.17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2147\/COPD.S183205","article-title":"Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years","volume":"14","author":"Mostafavi","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025112102450609000_71.2.415.18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-148-5-200803040-00005","article-title":"Brief communication: clinical implications of short-term variability in liver function test results","volume":"148","author":"Lazo","year":"2008","journal-title":"Ann Intern Med"},{"key":"2025112102450609000_71.2.415.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07460-y","article-title":"Genome-Wide association meta-analysis yields 20 loci associated with gallstone disease","volume":"9","author":"Ferkingstad","year":"2018","journal-title":"Nat Commun"},{"key":"2025112102450609000_71.2.415.20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrgastro.2016.86","article-title":"Critical comparison of elastography methods to assess chronic liver disease","volume":"13","author":"Friedrich-Rust","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025112102450609000_71.2.415.21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"2025112102450609000_71.2.415.22","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.cgh.2012.07.007","article-title":"Liver test results do not identify liver disease in adults with \u03b1(1)-antitrypsin deficiency","volume":"10","author":"Clark","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112102450609000_71.2.415.23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European liver transplant registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol"},{"key":"2025112102450609000_71.2.415.24","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A Protein-Truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N Engl J Med"},{"key":"2025112102450609000_71.2.415.25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","article-title":"Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis","volume":"68","author":"Strnad","year":"2019","journal-title":"Gut"},{"key":"2025112102450609000_71.2.415.26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thoraxjnl-2015-206906","article-title":"PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PimM COPD","volume":"70","author":"Green","year":"2015","journal-title":"Thorax"},{"key":"2025112102450609000_71.2.415.27","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/hmg\/ddy090","article-title":"Heteropolymerization of \u03b1-1-antitrypsin mutants in cell models mimicking heterozygosity","volume":"27","author":"Laffranchi","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2025112102450609000_71.2.415.28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1542-3565(05)00082-0","article-title":"Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency","volume":"3","author":"Bowlus","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112102450609000_71.2.415.29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"key":"2025112102450609000_71.2.415.30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"key":"2025112102450609000_71.2.415.31","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"2025112102450609000_71.2.415.32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J Hepatol"},{"key":"2025112102450609000_71.2.415.33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/hep.20118","article-title":"Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency","volume":"39","author":"Rudnick","year":"2004","journal-title":"Hepatology"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2020-323729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T10:45:45Z","timestamp":1763721945000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2020-323729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,11]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/gutjnl-2020-323729"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2020-323729","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}